卡培他滨和替莫唑胺：一项确保口服化疗安全处方的试点项目的设计、实施和初步结果。
Capecitabine and temozolomide: design, implementation, and preliminary outcomes from a pilot project to ensure safe prescribing of oral chemotherapy.
机构信息
Division of Medical Oncology, Mayo Clinic, Rochester, MN.
出版信息
J Oncol Pract. 2010 Jul;6(4):210-2. doi: 10.1200/JOP.200031. Epub 2010 Jun 22.
Abstract
Without adequate safety measures, oral chemotherapy can lead to undetected dosing errors. The Mayo Clinic launched a project to ensure that all capecitabine and temozolomide prescriptions receive an independent double check.
摘要
若无充分的安全措施，口服化疗药物可能导致剂量错误而未被察觉。梅奥诊所启动了一个项目，确保所有卡培他滨和替莫唑胺的处方都经过独立的双重核对。
相似文献
1
Capecitabine and temozolomide: design, implementation, and preliminary outcomes from a pilot project to ensure safe prescribing of oral chemotherapy.卡培他滨和替莫唑胺：一项确保口服化疗安全处方的试点项目的设计、实施和初步结果。
J Oncol Pract. 2010 Jul;6(4):210-2. doi: 10.1200/JOP.200031. Epub 2010 Jun 22.
2
The impacts of a pharmacist-managed outpatient clinic and chemotherapy-directed electronic order sets for monitoring oral chemotherapy.药剂师管理的门诊诊所及用于监测口服化疗的化疗指导电子医嘱集的影响
J Oncol Pharm Pract. 2017 Dec;23(8):582-590. doi: 10.1177/1078155216672314. Epub 2016 Oct 12.
3
The clinical and cost-effectiveness of oxaliplatin and capecitabine for the adjuvant treatment of colon cancer: systematic review and economic evaluation.奥沙利铂和卡培他滨辅助治疗结肠癌的临床疗效与成本效益：系统评价与经济学评估
Health Technol Assess. 2006 Nov;10(41):iii-iv, xi-xiv, 1-185. doi: 10.3310/hta10410.
4
A phase I study of thalidomide, capecitabine and temozolomide in advanced cancer.沙利度胺、卡培他滨和替莫唑胺用于晚期癌症的I期研究。
Cancer Biol Ther. 2007 Jun;6(6):840-5. doi: 10.4161/cbt.6.6.4099. Epub 2007 Mar 5.
5
Authors' Response to the Letter by Lamarca et al. Entitled "Temozolomide-Capecitabine Chemotherapy for Neuroendocrine Neoplasms: The Dilemma of Treatment Duration" Regarding "Activity and Safety of Standard and Prolonged Capecitabine/Temozolomide Administration in Patients with Advanced Neuroendocrine Neoplasms".作者对拉马尔卡等人题为《替莫唑胺-卡培他滨化疗治疗神经内分泌肿瘤：治疗持续时间的困境》的信件的回复，该信件针对《标准及延长卡培他滨/替莫唑胺给药方案在晚期神经内分泌肿瘤患者中的活性及安全性》。
Neuroendocrinology. 2020;110(1-2):158-160. doi: 10.1159/000503999. Epub 2019 Oct 10.
6
Activity and Safety of Standard and Prolonged Capecitabine/Temozolomide Administration in Patients with Advanced Neuroendocrine Neoplasms.标准和延长卡培他滨/替莫唑胺给药在晚期神经内分泌肿瘤患者中的活性和安全性。
Neuroendocrinology. 2019;109(4):333-345. doi: 10.1159/000500135. Epub 2019 Jun 3.
7
Using an enhanced oral chemotherapy computerized provider order entry system to reduce prescribing errors and improve safety.使用增强型口服化疗计算机化医嘱输入系统以减少处方错误并提高安全性。
Int J Qual Health Care. 2011 Feb;23(1):36-43. doi: 10.1093/intqhc/mzq066. Epub 2010 Nov 16.
8
Capecitabine and Temozolomide in Patients with Advanced Pulmonary Carcinoid Tumours.卡培他滨和替莫唑胺治疗晚期肺类癌肿瘤患者。
Neuroendocrinology. 2020;110(5):413-421. doi: 10.1159/000502864. Epub 2019 Aug 23.
9
First-line chemotherapy with capecitabine and temozolomide in patients with metastatic pancreatic endocrine carcinomas.卡培他滨和替莫唑胺一线治疗转移性胰腺神经内分泌癌患者。
Cancer. 2011 Jan 15;117(2):268-75. doi: 10.1002/cncr.25425. Epub 2010 Sep 7.
10
Clinical and cost-effectiveness of capecitabine and tegafur with uracil for the treatment of metastatic colorectal cancer: systematic review and economic evaluation.卡培他滨和替加氟尿嘧啶治疗转移性结直肠癌的临床疗效与成本效益：系统评价与经济学评估
Health Technol Assess. 2003;7(32):1-93. doi: 10.3310/hta7320.
引用本文的文献
1
Analyzing temozolomide medication errors: potentially fatal.分析替莫唑胺用药错误：可能致命。
J Neurooncol. 2014 Oct;120(1):111-5. doi: 10.1007/s11060-014-1523-1. Epub 2014 Jul 16.
本文引用的文献
1
Diagnostic errors in ambulatory care: dimensions and preventive strategies.门诊医疗中的诊断错误：维度与预防策略。
Adv Health Sci Educ Theory Pract. 2009 Sep;14 Suppl 1(0 1):57-61. doi: 10.1007/s10459-009-9177-z. Epub 2009 Aug 11.
2
Medication errors among adults and children with cancer in the outpatient setting.门诊环境中成年和儿童癌症患者的用药错误
J Clin Oncol. 2009 Feb 20;27(6):891-6. doi: 10.1200/JCO.2008.18.6072. Epub 2008 Dec 29.
3
Drug waste minimisation and cost-containment in Medical Oncology: two-year results of a feasibility study.肿瘤内科的药物浪费最小化与成本控制：一项可行性研究的两年结果
BMC Health Serv Res. 2008 Apr 1;8:70. doi: 10.1186/1472-6963-8-70.
4
NCCN Task Force Report: Oral chemotherapy.美国国立综合癌症网络（NCCN）特别工作组报告：口服化疗
J Natl Compr Canc Netw. 2008 Mar;6 Suppl 3:S1-14.
5
Organizational and cultural changes for providing safe patient care.为提供安全的患者护理而进行的组织和文化变革。
Qual Manag Health Care. 2005 Jul-Sep;14(3):132-43. doi: 10.1097/00019514-200507000-00002.
6
When silence threatens safety: lessons from the first Canberra Hospital neurosurgical inquiry.当沉默危及安全：堪培拉医院首次神经外科调查的教训
J Law Med. 2004 Aug;12(1):112-8.
7
Implications of dose rounding of chemotherapy to the nearest vial size.化疗剂量舍入至最接近的安瓿规格的影响。
Support Care Cancer. 2004 Sep;12(9):653-6. doi: 10.1007/s00520-004-0606-5.
8
Differences in the reporting of care-related patient injuries to existing reporting systems.向现有报告系统报告与护理相关的患者伤害情况存在差异。
Jt Comm J Qual Saf. 2003 Sep;29(9):460-7. doi: 10.1016/s1549-3741(03)29055-9.
9
Reporting on QI efforts for internal and external customers.向内部和外部客户汇报质量改进工作。
Jt Comm J Qual Improv. 1995 Jun;21(6):277-88. doi: 10.1016/s1070-3241(16)30148-1.
Zotero 插件